Exploring metabolite profiling of patients with secondary progressive multiple sclerosis
http://discovery.ucl.ac.uk/10043414/1/M ... t%20al.pdf
Synopsis
Proton magnetic resonance spectroscopic imaging (MRSI) quantifies brain metabolism in vivo and has the potential of uncovering the mechanism of action of therapeutic drugs.
In this study, we assessed the baseline metabolic profile of 161 patients with secondary progressive multiple sclerosis (SPMS) against a control population by applying a short TE PRESS MRSI protocol at 3T.
Based on the results the SPMS population could be divided into different groups (normal/biochemically abnormal) suggesting biochemical heterogeneity within SPMS patients
several types of alterations in NAWM and NAGM
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1680 Views
-
Last post by frodo
-
- 0 Replies
- 1121 Views
-
Last post by frodo
-
- 0 Replies
- 1166 Views
-
Last post by frodo
-
- 0 Replies
- 2253 Views
-
Last post by frodo
-
- 0 Replies
- 1765 Views
-
Last post by frodo
-
- 2 Replies
- 1022 Views
-
Last post by frodo
-
- 0 Replies
- 1212 Views
-
Last post by frodo
-
- 0 Replies
- 1757 Views
-
Last post by frodo
-
- 1 Replies
- 1333 Views
-
Last post by frodo